Search results
Results From The WOW.Com Content Network
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
In late December, Cytokinetics' shares jumped over 82% after aficamten met the main goal of a keenly awaited late-stage study, putting it on track to compete with a rival treatment from Bristol ...
NASDAQ Biotechnology Index. The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ -listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online .
On Monday, Reuters reported that Novartis is in the lead to acquire Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson. Novartis drops pursuit of Cytokinetics - source
Investing in biotechs is not for the faint of heart. Case in point: Cytokinetics (CYTK) shares cratered over 40% following the release of disappointing clinical trial results.Specifically, in the ...
20. 2008-11-24. 1,384.35. 1,480.41. +6.94%. +6.33%. Largest intraday percentage drops. An intraday percentage drop is defined as the difference between the previous trading session's closing price and the intraday low of the following trading session. The closing percentage change denotes the ultimate percentage change recorded after the ...
For premium support please call: 800-290-4726 more ways to reach us
James A. Spudich ( / ˈspʊdɪtʃ / [1]) is an American scientist and professor. He is the Douglass M. and Nola Leishman Professor of Biochemistry and of Cardiovascular Disease at Stanford University and works on the molecular basis of muscle contraction. He was awarded the Albert Lasker Basic Medical Research Award in 2012 with Michael Sheetz ...